Uplisting has a few items to clear up before its possibility. Is there any reference to use as speculation on big pharma partnership? I certainly believe it's possible, but want to know if there is a specific incident you are referencing.
It's entirely possible the run so far is just on speculation of great results on B and that others will see the greatness here. I gave B little chance of success, until very recently.
The stock is going up in anticipation of the Brilacidin un-blinding, which management announced would be in ~6 weeks and was very likely successful based on top-line results. A lot of investors feel the current CTIX price doesn't reflect the discounted market value of a more-likely successful Brilacidin antibiotic platform.
Market Data 
Markets 
AI
